August 12, 2025

Predicting Normal-Tension Glaucoma

New IOVS study recommends a polygenic approach towards advancing risk stratification in normal-tension glaucoma

The Ophthalmologist

August 11, 2025

FDA Approves Ketamine Product for Surgical Pain Management

PharmaTher has received FDA approval for KETARx, a ketamine therapy for surgical pain management.

Conexiant

August 11, 2025

Caught in the Middle: Dementia in Midlife

Proteomic profiling of spinal fluid may provide the early diagnostic clarity of frontotemporal dementia in younger populations

The Pathologist

August 11, 2025

Why Turning 26 Jeopardizes Health Coverage

A growing number of young Americans lose affordable health insurance at age 26, facing complex Affordable Care Act marketplaces, rising costs, and limited coverage options.

KFF Health News

August 08, 2025

Unprompted Speech Changes Found in ME/CFS

Nearly 1 in 10 individuals with myalgic encephalomyelitis/chronic fatigue syndrome reported voice or speech changes in a recent survey, despite not being directly asked about these symptoms.

Conexiant

July 23, 2025

Are Wearables Mining the Mind?

As neurotech devices move from clinics to consumers, states are racing to safeguard brainwave data from earbuds, sleep trackers, and AI-powered apps—raising new questions about privacy, consent, and medical ethics.

KFF Health News

January 14, 2025

Genetic Mutations in ANO3 Linked to Dystonia

Dysregulated Ca²⁺ signaling due to ANO3 mutations impairs K⁺ channel activation in striatal neurons, offering new insights into the pathophysiology of dystonia.

Conexiant

January 16, 2025

Vertigo, Emesis, Auditory Impairment: What's Your Diagnosis?

A patient presents with sudden-onset right-sided otalgia accompanied by vertigo, emesis, and auditory impairment. Your otoscope reveals an unexpected finding. What's your diagnosis?

Conexiant

December 11, 2024

ALS Drug Misses Trial Goals

A mid-stage trial for an experimental drug in ALS patients did not meet its main goal, with patients showing more gastrointestinal upset compared to a placebo, and differing death rates between groups. Results will be presented next year, and a long-term extension study will continue.

Reuters